KR102188689B1 - Process for preparing cefmetazole sodium - Google Patents

Process for preparing cefmetazole sodium Download PDF

Info

Publication number
KR102188689B1
KR102188689B1 KR1020180154644A KR20180154644A KR102188689B1 KR 102188689 B1 KR102188689 B1 KR 102188689B1 KR 1020180154644 A KR1020180154644 A KR 1020180154644A KR 20180154644 A KR20180154644 A KR 20180154644A KR 102188689 B1 KR102188689 B1 KR 102188689B1
Authority
KR
South Korea
Prior art keywords
sodium
cefmetazole
acid
solvent
crystallization
Prior art date
Application number
KR1020180154644A
Other languages
Korean (ko)
Other versions
KR20200068163A (en
Inventor
김정진
오영선
이영근
차영남
최경길
오기범
Original Assignee
(주)유케이케미팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)유케이케미팜 filed Critical (주)유케이케미팜
Priority to KR1020180154644A priority Critical patent/KR102188689B1/en
Publication of KR20200068163A publication Critical patent/KR20200068163A/en
Application granted granted Critical
Publication of KR102188689B1 publication Critical patent/KR102188689B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/32Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by an araliphatic carboxylic acid, which is substituted on the aliphatic radical by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

본 발명은 세프메타졸 소듐(Cefmetazole sodium) 제조방법에 관한 것으로, 세프메타졸 산(Cefmetazole acid)과 소듐 염을 유기용매에 용해한 후, 결정화 용매를 사용하여 반응 후 생성물의 결정화를 수행함으로써, 기존의 제조방법인 동결건조를 사용하지 않고 시간을 단축하면서 추가적인 설비 없이, 세프메타졸 소듐(Cefmetazole sodium)을 결정화에 의하여 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing Cefmetazole sodium, by dissolving Cefmetazole acid and sodium salt in an organic solvent, and then performing crystallization of the product after reaction using a crystallization solvent. The present invention relates to a method of preparing Cefmetazole sodium by crystallization without using freeze-drying, which is a manufacturing method of, and without additional equipment while shortening time.

Description

세프메타졸 소듐의 제조 방법{PROCESS FOR PREPARING CEFMETAZOLE SODIUM}Method for producing cefmethazole sodium TECHNICAL FIELD {PROCESS FOR PREPARING CEFMETAZOLE SODIUM}

본 발명은 세파마이신 또는 2세대 세팔로스포린계 항생제로 분류되는 세프메타졸 소듐(Cefmetazole Sodium)을 결정화법을 통하여 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing cefamycin or Cefmetazole Sodium classified as a second-generation cephalosporin antibiotic through a crystallization method.

세프메타졸 소듐은 Sankyo(Japan)사가 개발한 제품으로, 박테로이드, 포도상구균 등의 세균감염에 강력한 살균효과를 나타내며, 1세대 세팔로스포린계 항생제보다 더 넓은 범위의 항생 효과를 나타내는 것으로 알려져 있다.Cefmethazole sodium, a product developed by Sankyo (Japan), has a strong bactericidal effect on bacterial infections such as bacteroids and staphylococcus, and is known to exhibit a broader spectrum of antibiotic effects than the first generation cephalosporin antibiotic .

이러한 세팔로스포린계 항생제는 세균이 세포벽을 형성하는 데 있어, 저해작용을 하여 세균의 세포 내에 삼투압의 변화로 인하여 세포가 파괴된다.These cephalosporin antibiotics act as an inhibitory action in forming cell walls of bacteria, and cells are destroyed due to changes in osmotic pressure within the cells of the bacteria.

특허 GB 1449420호에 기재된 바에 의하면, 상응하는 카르복시-보호된 7β-아미노-7α-메톡시-3-(1-메틸-1H-테트라졸-5-일)티오메틸-3-세펨-4-산을 2-(시아노메틸티오)아세트산과 축합반응 시키고, 카르복시-보호기를 탈보호화하여 세프메타졸 산(Cefmetazole acid)을 얻는다.As described in patent GB 1449420, the corresponding carboxy-protected 7β-amino-7α-methoxy-3-(1-methyl-1H-tetrazol-5-yl)thiomethyl-3-cefem-4-ic acid Is subjected to a condensation reaction with 2-(cyanomethylthio)acetic acid, and the carboxy-protecting group is deprotected to obtain Cefmetazole acid.

합성한 세프메타졸 산(Cefmetazole acid)은 소듐 염 형태로 결정화하여 세프메타졸 소듐(Cefmetazole sodium)을 제조한다.The synthesized cefmetazole acid is crystallized in the form of a sodium salt to prepare cefmetazole sodium.

이때 염 변경 물질로 탄산수소나트륨(Sodium hydrogen carbonate)을 사용하여 용액의 pH를 조절한 후 동결건조하여 시판되고 있다.At this time, the pH of the solution is adjusted using sodium hydrogen carbonate as a salt change material, and then freeze-dried and marketed.

그리고 중국공개특허공보 제200910014972.5호에서도 동결건조방법에 의한 세프메타졸 소듐을 제조하는 방법이 기재되어 있다. In addition, a method of preparing cefmethazole sodium by a freeze-drying method is described in Chinese Patent Application Publication No. 200910014972.5 .

이러한 동결건조 제조방법은 잔류용매 제거 및 안정한 상태로 결정을 얻는 장점이 있으나, 공정 특성상 별도의 설비를 필요로 하며 공정시간이 길고 설비의 운용 비용이 높은 단점이 있다.This freeze-dried manufacturing method has the advantage of removing residual solvent and obtaining crystals in a stable state, but it requires a separate facility due to the nature of the process, has a long process time and high facility operating cost.

GBGB 14494201449420 AA CNCN 200910014972200910014972 AA

본 발명은 현재 판매되고 있는 세프메타졸 소듐을 높은 단가와 추가설비가 필요한 동결건조를 사용하지 않고, 결정화 방법을 통하여 높은 수율의 경제적인 제조방법을 제공하기 위한 것이다.The present invention is to provide an economical manufacturing method of high yield through a crystallization method without the use of freeze-drying that requires a high unit cost and additional equipment for cefmethazole sodium currently sold.

상기한 기술적 과제를 해결하고자 본 발명은, 세프메타졸 산(Cefmetazole acid)을 유기용매에 용해시키고 유기소듐염을 가하여 반응시킨 후, 반응 생성물을 결정화 용매에 첨가하여 세프메타졸 소듐(Cefmetazole sodium)을 결정화하는 제조방법을 제공한다.In order to solve the above technical problem, the present invention dissolves Cefmetazole acid in an organic solvent and reacts by adding an organic sodium salt, and then adding the reaction product to a crystallization solvent to obtain Cefmetazole sodium. It provides a manufacturing method for crystallizing.

동결건조를 이용한 세프메타졸 소듐(Cefmetazole sodium)의 제조 방법은, 제조공정 특성상 물을 제거해야 하기에 공정시간이 길어지고 설비 운용비용이 높아진다.The manufacturing method of Cefmetazole sodium using freeze-drying requires removal of water due to the nature of the manufacturing process, so the process time is lengthened and the equipment operation cost is high.

본 발명에 따른 세프메타졸 소듐(Cefmetazole sodium) 제조방법에 따르면, 특정 유기소듐염을 사용함으로써 일반적 세파계 항생제 제조시설로 결정화하여 공정시간을 단축시키며, 고수율의 세프메타졸 소듐(Cefmetazole sodium)을 제조할 수 있어 매우 경제적인 효과가 있는 것이다.According to the method for preparing Cefmetazole sodium according to the present invention, by using a specific organic sodium salt, the process time is shortened by crystallization in a general cepha-based antibiotic manufacturing facility, and a high yield of Cefmetazole sodium It has a very economical effect because it can be manufactured.

이하, 본 발명을 실시예 등을 참조하여 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail with reference to examples and the like.

본 발명의 세프메타졸 소듐(Cefmetazole sodium)의 제조방법은, 아래의 화학식 1에서 보는 바와 같이 주요 성분인 세프메타졸 산(Cefmetazole acid)을 유기용매에 용해 후, 유기용매에 용해가 가능한 특정 유기소듐염을 가하여 반응시킨 생성물을 결정화 용매를 이용한 결정화 단계를 포함한다.In the method for preparing Cefmetazole sodium of the present invention, as shown in Formula 1 below, after dissolving Cefmetazole acid, the main component, in an organic solvent, it is possible to dissolve in an organic solvent. The product reacted by adding sodium salt is crystallized using a crystallization solvent.

<화학식 1><Formula 1>

Figure 112018121473832-pat00001
Figure 112018121473832-pat00001

구체적으로 본 발명은 세프메타졸 산(Cefmetazole acid)을 유기용매에 용해시킨 후, 유기소듐염을 첨가하고 교반하면서 반응시킨다.Specifically, in the present invention, after dissolving Cefmetazole acid in an organic solvent, an organic sodium salt is added and reacted with stirring.

상기 반응액을 냉각한 결정화 용매에 적가한 후 적정시간 동안 온도를 유지하며 교반, 결정화 시킨다.The reaction solution is added dropwise to the cooled crystallization solvent, and then stirred and crystallized while maintaining the temperature for an appropriate time.

상기 결정화 용액에서 결정을 여과하고 동일한 용매로 세척한다.The crystals are filtered in the crystallization solution and washed with the same solvent.

여과된 결정을 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium)을 제조하였다.The filtered crystals were dried under reduced pressure to prepare off-white solid Cefmetazole sodium.

본 발명의 제조방법에서 세프메타졸 산(Cefmetazole acid)을 용해하기 위하여 사용되는 유기용매로 아세톤, 아세토니트릴(ACN), 디메틸설폭사이드(DMSO), 디메틸포름아마이드(DMF), 디메틸아세트아마이드(DMAc), 테트라하이드로퓨란(THF), 메탄올, 에탄올을 사용할 수 있으며, 바람직하게는 아세톤을 사용한다.Acetone, acetonitrile (ACN), dimethylsulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMAc) as an organic solvent used to dissolve Cefmetazole acid in the manufacturing method of the present invention. ), tetrahydrofuran (THF), methanol, and ethanol may be used, and acetone is preferably used.

본 발명의 제조방법에서는, 세프메타졸 산(Cefmetazole acid)에 대한 용매의 무게 비는 9 내지 13배, 바람직하게는 9.5 내지 12.5배, 가장 바람직하게는 10배 내지 11배일 수 있다.In the production method of the present invention, the weight ratio of the solvent to cefmetazole acid may be 9 to 13 times, preferably 9.5 to 12.5 times, and most preferably 10 to 11 times.

용매의 양이 상기 수치 범위보다 적은 경우 세프메타졸 산(Cefmetazole acid)의 용해성이 좋지 않아 소듐 염(salt)화 반응이 불충분하게 일어날 수 있고, 용매 양이 상기 수치 범위보다 많은 경우 높은 수율 등의 효과를 얻을 수 없다.If the amount of the solvent is less than the above numerical range, the solubility of Cefmetazole acid may be insufficient, so that the sodium salt reaction may be insufficient, and if the amount of the solvent is greater than the above numerical range, high yield, etc. The effect cannot be obtained.

본 발명의 제조방법에서 사용되는 유기소듐 염은 소듐 2-에틸 헥사노에이트(sodium 2-ethyl hexanoate), 소듐 아세테이트 (sodium acetate), 소듐 포르메이트(sodium formate), 소듐 프로피오네이트(sodium propionate), 소듐 뷰티레이트(sodium butylate), 소듐 벤조에이트(sodiumbenzoate), 소듐 옥타노에이트(sodium octanoate), 소듐 락테이트(sodium lactate), 소듐 말로네이트(sodium malonate), 소듐 이소발레레이트(sodium isovalerate), 소듐 2-옥소 뷰티레이트(sodium 2-oxo butylate), 소듐 피루베이트(sodium pyruvate), 소듐 트리메틸아세테이트(sodium trimethylacetate) 및 소듐 올레이트(sodium oleate) 등을 사용할 수 있으며, 바람직하게는 소듐 2-에틸 헥사노에이트를 사용한다.The organic sodium salt used in the manufacturing method of the present invention is sodium 2-ethyl hexanoate, sodium acetate, sodium formate, sodium propionate , Sodium butylate, sodium benzoate, sodium octanoate, sodium lactate, sodium malonate, sodium isovalerate, Sodium 2-oxo butyrate (sodium 2-oxo butylate), sodium pyruvate (sodium pyruvate), sodium trimethylacetate (sodium trimethylacetate), sodium oleate (sodium oleate), etc. can be used, preferably sodium 2-ethyl Use hexanoate.

본 발명의 제조방법에서는, 세프메타졸 산 1 당량을 기준으로 유기소듐 염 1.0 당량 내지 1.5 당량, 바람직하게는 1.0 당량 내지 1.3 당량 더욱 바람직하게는 1.05 당량 1.1 당량 사용할 수 있다.In the production method of the present invention, 1.0 equivalent to 1.5 equivalents of organic sodium salt, preferably 1.0 to 1.3 equivalents, more preferably 1.1 equivalents of 1.05 equivalents based on 1 equivalent of cefmethazole acid may be used.

유기소듐 염의 함량이 상기 수치의 범위보다 적은 경우, 반응이 충분히 일어나지 않아 최종 세프메타졸 소듐이 생성되지 않고, 물에 용해되지 않는 세프메타졸 산이 고체로 잔류하게 된다.When the content of the organosodium salt is less than the above range, the reaction does not sufficiently occur, so that the final cefmethazole sodium is not produced, and the cefmethazole acid insoluble in water remains as a solid.

상기 수치의 범위보다 많은 경우는 반응 후 잔류된 소듐염이 결정으로 석출되어 세프메타졸의 함량이 낮아지게 된다.If it is more than the above range, the sodium salt remaining after the reaction is precipitated as crystals, so that the content of cefmethazole is lowered.

본 발명의 제조방법에서 소듐 염(salt)화 반응 후 결정화를 위해 사용되는 용매는 에틸 아세테이트(Ethyl acetate), 노말 헥산(n-Hexane), 디클로로메탄(Dichloromethane), 사이클로헥산(Cyclohexane), 이소프로필 에테르(Isopropyl ether), 펜탄(Pentane), 톨루엔(Toluene), t-부틸메틸에테르(t-butylmethyl ether), 이소프로판올(Isopropanol) 등을 사용할 수 있다.In the production method of the present invention, the solvent used for crystallization after the sodium salt reaction is ethyl acetate, n-Hexane, dichloromethane, cyclohexane, isopropyl Ether (Isopropyl ether), pentane (Pentane), toluene (Toluene), t-butylmethyl ether (t-butylmethyl ether), isopropanol (Isopropanol) and the like can be used.

본 발명의 제조방법에서 반응 온도는 0℃ 내지 20℃에서 수행할 수 있으며, 바람직하게는 5℃ 내지 10℃에서 반응을 수행한다.In the manufacturing method of the present invention, the reaction temperature may be performed at 0°C to 20°C, and preferably at 5°C to 10°C.

반응 온도가 상기 수치의 범위보다 낮은 경우 반응이 충분히 일어나지 않으며, 용해도 또한 낮아져 최종 세프메타졸 소듐(Cefmetazole sodium)이 제대로 생성되지 않아 물에 녹지 않는 잔류물이 생성될 수 있다.If the reaction temperature is lower than the above range, the reaction does not occur sufficiently, the solubility is also lowered, and the final Cefmetazole sodium is not properly produced, resulting in a water-insoluble residue.

상기 수치의 범위보다 높은 경우 세프메타졸 산의 안정성이 떨어져 불순물이 발생할 수 있다.If the value is higher than the above range, the stability of cefmethazole acid may decrease, and impurities may occur.

이하 실시예를 통하여 본 발명을 보다 상세하게 설명한다.The present invention will be described in more detail through the following examples.

그러나 본 발명의 범위가 이들로 한정되는 것은 아니다.However, the scope of the present invention is not limited to these.

세프메타졸 산(Cefmetazole acid) 20g을 5℃의 아세톤 240mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 7.40g을 첨가하였다. 이를 교반하면서 반응 온도를 5℃ 유지하며 1시간 반응시킨다. 이후 5℃로 냉각한 펜탄(Pentane) 720mL에 반응액을 적가한다. 이후 1시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 펜탄(Pentane)으로 세척하였다. 여과된 결정을 40℃에서 12시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 93.8%)을 얻었다.After dissolving 20 g of cefmetazole acid in 240 mL of acetone at 5°C, 7.40 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature is maintained at 5° C. and reacted for 1 hour. Thereafter, the reaction solution was added dropwise to 720 mL of pentane cooled to 5°C. After that, the mixture is stirred while maintaining the temperature for 1 hour. The crystals were filtered and washed with pentane. The filtered crystals were dried under reduced pressure at 40° C. for 12 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 93.8%).

세프메타졸 산(Cefmetazole acid) 20g을 5℃의 아세톤 240mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 7.75g을 첨가하였다. 이를 교반하면서 반응 온도를 5℃ 유지하며 1시간 반응시킨다. 이후 5℃로 냉각한 펜탄(Pentane) 720mL에 반응액을 적가한다. 이후 1시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 펜탄(Pentane)으로 세척하였다. 여과된 결정을 상온에서 1시간가량 질소 충진하며 용매를 제거한다. 이후 40℃에서 12시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 95.7%)을 얻었다.After dissolving 20 g of Cefmetazole acid in 240 mL of acetone at 5° C., 7.75 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature is maintained at 5° C. and reacted for 1 hour. Thereafter, the reaction solution was added dropwise to 720 mL of pentane cooled to 5°C. After that, the mixture is stirred while maintaining the temperature for 1 hour. The crystals were filtered and washed with pentane. The filtered crystals are charged with nitrogen at room temperature for about 1 hour to remove the solvent. Thereafter, it was dried under reduced pressure at 40° C. for 12 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 95.7%).

세프메타졸 산(Cefmetazole acid) 10g을 5℃의 아세톤 120mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 5.28g을 첨가하였다. 이를 교반하면서 반응 온도를 5℃ 유지하며 1시간 반응시킨다. 이후 5℃로 냉각한 펜탄(Pentane) 720mL에 반응액을 적가한다. 이후 1시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 펜탄(Pentane)으로 세척하였다. 여과된 결정을 40℃에서 12시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 93.6%)을 얻었다.After dissolving 10 g of Cefmetazole acid in 120 mL of acetone at 5°C, 5.28 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature is maintained at 5° C. and reacted for 1 hour. Thereafter, the reaction solution was added dropwise to 720 mL of pentane cooled to 5°C. After that, the mixture is stirred while maintaining the temperature for 1 hour. The crystals were filtered and washed with pentane. The filtered crystals were dried under reduced pressure at 40° C. for 12 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 93.6%).

세프메타졸 산(Cefmetazole acid) 10g을 10℃의 아세톤 120mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 3.70g을 첨가하였다. 이를 교반하면서 반응 온도를 10℃ 유지하며 0.5시간 반응시킨다. 이후 10℃로 냉각한 에틸 아세테이트(Ethyl acetate) 280mL에 반응액을 적가한다. 이후 1시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 에틸 아세테이트(Ethyl acetate) 50mL로 세척하였다. 여과된 결정을 40℃에서 12시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 93%)을 얻었다.After dissolving 10 g of cefmetazole acid in 120 mL of acetone at 10° C., 3.70 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature was maintained at 10° C. and reacted for 0.5 hours. Then, the reaction solution was added dropwise to 280 mL of ethyl acetate cooled to 10°C. After that, the mixture is stirred while maintaining the temperature for 1 hour. The crystals were filtered and washed with 50 mL of ethyl acetate. The filtered crystals were dried under reduced pressure at 40° C. for 12 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 93%).

세프메타졸 산(Cefmetazole acid) 10g을 10℃의 아세톤 140mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 3.70g을 첨가하였다. 이를 교반하면서 반응 온도를 10℃ 유지하며 0.5시간 반응시킨다. 이후 10℃로 냉각한 에틸 아세테이트(Ethyl acetate) 280mL에 반응액을 적가한다. 이후 1시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 에틸 아세테이트(Ethyl acetate) 50mL로 세척하였다. 여과된 결정을 상온에서 2시간가량 질소 충진하며 용매를 제거한다.After dissolving 10 g of cefmetazole acid in 140 mL of acetone at 10° C., 3.70 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature was maintained at 10° C. and reacted for 0.5 hours. Then, the reaction solution was added dropwise to 280 mL of ethyl acetate cooled to 10°C. After that, the mixture is stirred while maintaining the temperature for 1 hour. The crystals were filtered and washed with 50 mL of ethyl acetate. The filtered crystals are charged with nitrogen at room temperature for about 2 hours to remove the solvent.

이후 40℃에서 12시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 93%)을 얻었다.Thereafter, it was dried under reduced pressure at 40° C. for 12 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 93%).

세프메타졸 산(Cefmetazole acid) 110g을 10℃의 아세톤 140mL에 용해시킨 후, 소듐 2-에틸헥사노에이트(Sodium 2-ethylhexanoate) 40.71g을 첨가하였다. 이를 교반하면서 반응 온도를 10℃ 유지하며 0.5시간 반응시킨다. 이후 10℃로 냉각한 에틸 아세테이트(Ethyl acetate) 280mL에 반응액을 적가한다. 이후 0.5시간 동안 온도를 유지하며 교반한다. 결정을 여과하고 에틸 아세테이트(Ethyl acetate) 50mL로 세척하였다. 여과된 결정을 상온에서 2시간가량 질소 충진하며 용매를 제거한다. 이후 40℃에서 40시간 감압 건조하여 미백색의 고체 세프메타졸 소듐(Cefmetazole sodium, 수율: 93.5%)을 얻었다.After dissolving 110 g of cefmetazole acid in 140 mL of acetone at 10° C., 40.71 g of sodium 2-ethylhexanoate was added. While stirring this, the reaction temperature was maintained at 10° C. and reacted for 0.5 hours. Then, the reaction solution was added dropwise to 280 mL of ethyl acetate cooled to 10°C. Then, the mixture is stirred while maintaining the temperature for 0.5 hours. The crystals were filtered and washed with 50 mL of ethyl acetate. The filtered crystals are charged with nitrogen at room temperature for about 2 hours to remove the solvent. Thereafter, it was dried under reduced pressure at 40° C. for 40 hours to obtain an off-white solid cefmetazole sodium (Cefmetazole sodium, yield: 93.5%).

Claims (5)

세프메타졸 산(Cefmetazole acid)을 유기용매에 녹인 후 유기소듐 염을 첨가하여 반응시키고, 반응 후 생성물을 결정화 용매에 의하여 결정화를 수행하는 단계를 포함하고,
상기 유기용매는 아세톤, 아세토니트릴(ACN), 디메틸설폭사이드(DMSO), 디메틸포름아마이드(DMF), 디메틸아세트아마이드(DMAc), 테트라하이드로퓨란(THF), 메탄올 및 에탄올로 이루어진 군으로부터 선택되고,
상기 유기소듐 염은 소듐 2-에틸 헥사노에이트(sodium 2-ethyl hexanoate)이고,
상기 결정화 용매는 에틸 아세테이트(ethyl acetate) 또는 펜탄(pentane)인 것을 특징으로 하는, 세프메타졸 소듐(Cefmetazole sodium)의 제조방법.
Dissolving Cefmetazole acid in an organic solvent, reacting by adding an organic sodium salt, and performing crystallization of the product after the reaction using a crystallization solvent,
The organic solvent is selected from the group consisting of acetone, acetonitrile (ACN), dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMAc), tetrahydrofuran (THF), methanol and ethanol,
The organosodium salt is sodium 2-ethyl hexanoate,
The crystallization solvent is ethyl acetate or pentane, characterized in that, Cefmetazole sodium (Cefmetazole sodium) production method.
삭제delete 제1항에 있어서,
세프메타졸 산(Cefmetazole acid) 1 당량을 기준으로 유기소듐 염 1.0 내지 1.5 당량을 사용하는 것을 특징으로 하는 세프메타졸 소듐Cefmetazole sodium)의 제조방법.
The method of claim 1,
A method for preparing cefmetazole sodium), characterized in that 1.0 to 1.5 equivalents of an organic sodium salt are used based on 1 equivalent of Cefmetazole acid.
삭제delete 제1항에 있어서,
반응온도는 0 내지 20℃인 것을 특징으로 하는 세프메타졸 소듐(Cefmetazole sodium)의 제조방법.
The method of claim 1,
The reaction temperature is a method for producing cefmetazole sodium, characterized in that 0 to 20 ℃.
KR1020180154644A 2018-12-04 2018-12-04 Process for preparing cefmetazole sodium KR102188689B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180154644A KR102188689B1 (en) 2018-12-04 2018-12-04 Process for preparing cefmetazole sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180154644A KR102188689B1 (en) 2018-12-04 2018-12-04 Process for preparing cefmetazole sodium

Publications (2)

Publication Number Publication Date
KR20200068163A KR20200068163A (en) 2020-06-15
KR102188689B1 true KR102188689B1 (en) 2020-12-09

Family

ID=71081606

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180154644A KR102188689B1 (en) 2018-12-04 2018-12-04 Process for preparing cefmetazole sodium

Country Status (1)

Country Link
KR (1) KR102188689B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1449420A (en) 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1449420A (en) 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
KR20200068163A (en) 2020-06-15

Similar Documents

Publication Publication Date Title
KR101719366B1 (en) Process for preparing amorphous refaximin and the amorphous refaximin thus obtained
US20100286417A1 (en) Crystalline Minocycline Base and Processes for its Preparation
KR101471735B1 (en) Raltegravir salts and crystalline forms thereof
JP6378844B2 (en) Method for preparing sixth crystalline form of sofosbuvir
CN105669679A (en) Preparation method of PCI-32765 crystal form A
KR100939216B1 (en) Process for preparing Pantoprazole Sodium Sesquihydrate
CN109867687B (en) High water-soluble amoxicillin and preparation method thereof
KR102188689B1 (en) Process for preparing cefmetazole sodium
CN107201391B (en) Synthesis method of cefepime hydrochloride
EP1509500B1 (en) Process for the preparation of the amorphous form of atorvastatin calcium salt
CN110143973B (en) Preparation process of flomoxef sodium
WO2017001996A1 (en) A process for preparing raltegravir potassium form 3
CN106279108B (en) A kind of method of industrialized production Rabeprazole and dextral-rabeprazole intermediate
KR20180105450A (en) A Method of preparing Fimarsartan choline salt and hydrate thereof
EP2690097B1 (en) Method for crystallizing glutamic acid benzyl ester n-carboxylic anhydride
KR101694262B1 (en) Process for preparing crystalline forms of silodosin
CN116283810B (en) Preparation method of isoxazole compound
CN102391170A (en) Method for preparing N,N-diallyl-5-methoxytryptamine hydrochlorides
CN107417630B (en) Synthesis method of N-ethyl-2, 3-dioxopiperazine
JP2006111561A (en) Method for producing 1/2 hydrate of antimicrobial agent
EP4182306A1 (en) 4-furanamides and method for the production thereof
KR101670857B1 (en) Method for preparing cefroxadine
CN111187282A (en) Process for preparing cephradine oxide D
KR20220044684A (en) Salicylamine Acetate Preparation Method
KR100357816B1 (en) Process for the preparation of amorphous cefuroxime axetil and the isolation process thereof

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant